Guiguang Cheng
- Pharmacology top 0.5%
- Alkaloids: synthesis and pharmacology 28
- Drug-Induced Hepatotoxicity and Protection 10
- Biochemistry top 1%
- Phytochemicals and Antioxidant Activities 30
- Traditional and Medicinal Uses of Annonaceae 21
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities 30
- Traditional and Medicinal Uses of Annonaceae 21
- Pharmacology top 2%
- Alkaloids: synthesis and pharmacology 28
- Drug-Induced Hepatotoxicity and Protection 10
- Food Science top 2%
-
- Natural product bioactivities and synthesis 19
- Phytochemical compounds biological activities 12
-
- Phytochemistry and Biological Activities 14
-
- Phytochemistry and Bioactive Compounds 12
- Co-authors
- Yaping LiuJianxin CaoAfsar KhanShengbao CaiTianrui ZhaoXiao‐Dong LuoYudan WangMeilian Yang
- Cited by
- PharmacologyBiochemistry
- Journals
- Journal of the American Chemical Society (1 paper)SHILAP Revista de lepidopterología (3 papers)Analytical Chemistry (1 paper)
In The Last Decade
Guiguang Cheng
145 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 119
- Pharmacology 706
- Biochemistry 439
- Biochemistry 284
- Pharmacology 496
- Food Science 401
Countries citing papers authored by Guiguang Cheng
This map shows the geographic impact of Guiguang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiguang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiguang Cheng more than expected).
Fields of papers citing papers by Guiguang Cheng
This network shows the impact of papers produced by Guiguang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiguang Cheng. The network helps show where Guiguang Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guiguang Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 42 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 9 | |
| 17 | 2021 | 20 | |
| 18 | 2021 | 6 | |
| 19 | 2020 | 4 | |
| 20 | 2019 | 33 |
About Guiguang Cheng
Guiguang Cheng is a scholar working on Pharmacology, Biochemistry and Biochemistry, having authored 154 papers that have together received 2.8k indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (30 papers), Alkaloids: synthesis and pharmacology (28 papers), Traditional and Medicinal Uses of Annonaceae (21 papers), Natural product bioactivities and synthesis (19 papers), Phytochemistry and Biological Activities (14 papers), Phytochemistry and Bioactive Compounds (12 papers), Phytochemical compounds biological activities (12 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). The work is most often cited by research in Pharmacology (706 citations), Biochemistry (439 citations) and Biochemistry (284 citations). Guiguang Cheng has collaborated with scholars based in China, Pakistan and Australia. Frequent co-authors include Yaping Liu, Jianxin Cao, Afsar Khan, Shengbao Cai, Tianrui Zhao, Xiao‐Dong Luo, Yudan Wang, Meilian Yang, Yanli Ma and Yijia Jia. Their work appears in journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.